We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Clover Corporation is a packaged foods business based in Australia. Clover Corporation shares (CLV) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Clover Corporation has a trailing 12-month revenue of around $60.8 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
| 52-week range | $1.2 - $1.8818 |
|---|---|
| 50-day moving average | $1.3491 |
| 200-day moving average | $1.5233 |
| Target price | $1.63 |
| PE ratio | 38.7879 |
| Dividend yield | $0.01 (0.76%) |
| Earnings per share (TTM) | $0.033 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$1.275
| 1 week (2022-06-03) | -3.41% |
|---|---|
| 1 month (2022-05-11) | 1.19% |
| 3 months (2022-03-11) | -6.93% |
| 6 months (2021-12-10) | -27.14% |
| 1 year (2021-06-11) | -28.57% |
|---|---|
| 2 years (2020-06-11) | -42.05% |
| 3 years (2019-06-11) | -37.19% |
| 5 years (2017-06-09) | 183.33% |
Valuing Clover Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Clover Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Clover Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Clover Corporation shares trade at around 39x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Clover Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.1 million (£0.0 million).
The EBITDA is a measure of a Clover Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $60.8 million |
|---|---|
| Operating margin TTM | 13.77% |
| Gross profit TTM | $18.2 million |
| Return on assets TTM | 6.82% |
| Return on equity TTM | 9.54% |
| Profit margin | 9.05% |
| Book value | 0.357 |
| Market capitalisation | $213 million |
TTM: trailing 12 months
Dividend payout ratio: 33.33% of net profits
Recently Clover Corporation has paid out, on average, around 33.33% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.76% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Clover Corporation shareholders could enjoy a 0.76% return on their shares, in the form of dividend payments. In Clover Corporation's case, that would currently equate to about A$0.01 per share.
While Clover Corporation's payout ratio might seem fairly standard, it's worth remembering that Clover Corporation may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 5 April 2022 (the "ex-dividend date").
Over the last 12 months, Clover Corporation's shares have ranged in value from as little as $1.2 up to $1.8818. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Clover Corporation's is 0.6079. This would suggest that Clover Corporation's shares are less volatile than average (for this exchange).
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated powders; and research and product development of functional food and infant nutrition ingredients. The company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. It offers products in the areas of active living-immune system and sports, healthy living?brain and heart, and starting out-infant and child. The company was founded in 1988 and is headquartered in Altona North, Australia.
Everything we know about the Bayrock Resources IPO, plus information on how to buy in.
Everything we know about the Critical Minerals Group IPO, plus information on how to buy in.
Everything we know about the Chalkos Metals Limited IPO, plus information on how to buy in.
Steps to owning and managing Cluey shares.
Steps to owning and managing Koba Resources shares.
Steps to owning and managing Rincon Resource shares.
Steps to owning and managing Payright shares.
Everything we know about the Iltani Resources IPO, plus information on how to buy in.
Bloom Impact Investing offers exclusively climate impact investing, with direct climate action being the goal.
Steps to owning and managing Kingfisher Mining shares.
